This retrospective study of patients treated with immune checkpoint inhibitors highlights cancer-specific patterns of end-of-life use, the risks and timing of immune-related adverse events, and the critical need for patient-centered...
This retrospective study of patients treated with immune checkpoint inhibitors highlights cancer-specific patterns of end-of-life use, the risks and timing of immune-related adverse events, and the critical need for patient-centered...
In this episode of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the crucial difference between cancer screening and true cancer prevention, highlighting how lifestyle changes, vaccines, and emerging therapies...
In this episode of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the crucial difference between cancer screening and true cancer prevention, highlighting how lifestyle changes, vaccines, and emerging therapies...
Lung cancer mortality has fallen substantially across the United States since 1999, but deep regional, gender, racial, and state-level disparities persist despite overall progress, according to a study published in Respiratory Research.
Lung cancer mortality has fallen substantially across the United States since 1999, but deep regional, gender, racial, and state-level disparities persist despite overall progress, according to a study published in Respiratory Research.
Virtual, community-based cancer screening programs significantly improve access to early detection services, especially in underserved populations, according to a study presented at the ASCO Annual Meeting.
Virtual, community-based cancer screening programs significantly improve access to early detection services, especially in underserved populations, according to a study presented at the ASCO Annual Meeting.
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...